FOLD

#1193
Amicus Therapeutics, Inc
14.3700
+0.24%
Sector:
Básica:
Profit Currency:
Rango diario
14.3700
14.3700
Rango anual
8.6200
14.3800
Cambio diario
+0.24%
Monthly Change
+0.63%
6 month change
+65.94%
Cambio anual
+65.94%
Cierres anteriores
14.3350
Open
14.3700
Bid
Ask
Low
14.3700
High
14.3700
Volumen
104
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 4.4312 B
  • Employee 499
  • Founded 2002
  • CEO Bradley L Campbell
  • Website www.amicusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG000PLF6N0
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-158.22
Price to sales ratio
6.92
Dividends per share
—
Dividend yield %
—

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Noticias